|
MORF4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.94739999995297E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.07199999999941E-05 |
| Normal-vs-Stage2 |
1.338320E-03 |
| Normal-vs-Stage3 |
1.790270E-04 |
| Normal-vs-Stage4 |
1.73409999999485E-05 |
| Stage1-vs-Stage2 |
7.173600E-01 |
| Stage1-vs-Stage3 |
7.350800E-01 |
| Stage1-vs-Stage4 |
9.554400E-02 |
| Stage2-vs-Stage3 |
9.226000E-01 |
| Stage2-vs-Stage4 |
3.355200E-01 |
| Stage3-vs-Stage4 |
2.162400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.36080000000083E-05 |
| Normal-vs-AfricanAmerican |
2.803900E-02 |
| Normal-vs-Asian |
2.003800E-03 |
| Caucasian-vs-AfricanAmerican |
7.566800E-01 |
| Caucasian-vs-Asian |
8.899200E-01 |
| AfricanAmerican-vs-Asian |
8.591600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.24289999590277E-08 |
| Normal-vs-Female |
8.21220000000178E-05 |
| Male-vs-Female |
2.569700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.045530E-04 |
| Normal-vs-Age(41-60Yrs) |
6.48739999999925E-05 |
| Normal-vs-Age(61-80Yrs) |
4.88430000000761E-06 |
| Normal-vs-Age(81-100Yrs) |
6.279900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.313000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.136200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.998200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.318000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.148000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.824400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.071800E-01 |
| Classical-VS-Follicular |
1.522270E-03 |
| Classical-VS-Other |
1.114640E-01 |
| Classical-VS-Normal |
2.559900E-04 |
| Tall-VS-Follicular |
2.196800E-01 |
| Tall-VS-Other |
2.873600E-01 |
| Tall-VS-Normal |
4.818800E-03 |
| Follicular-VS-Other |
5.998800E-01 |
| Follicular-VS-Normal |
1.68290000046589E-07 |
| Other-VS-Normal |
5.937900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.83449999980168E-07 |
| Normal-vs-N1 |
3.89469999995118E-06 |
| N0-vs-N1 |
3.537200E-01 |
|
|
